Publications found:
42,841
Sort by:
Innovative Pap Smear/HPV Testing Technologies and Emerging Markets
US$ 3,080.00
... 243 pages, 7 tables and presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, ... analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies ...
November 2012
243 pages
Innovative Prostatic Acid Phosphatase Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 242 pages and 11 ...
November 2012
242 pages
Innovative PSA Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 249 pages and 15 ...
November 2012
249 pages
Innovative Blood Banking Technologies and Emerging Markets
US$ 19,040.00
... potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next ten years, and to assist ... where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for ...
November 2012
800 pages
Innovative Cancer Diagnostic Technologies and Emerging Markets
US$ 18,960.00
... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
November 2012
1200 pages
Innovative Coagulation Testing Technologies and Emerging Markets
US$ 19,120.00
... , offering opportunities for quality control products and services. Moreover, continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
November 2012
650 pages
Innovative Infectious Disease Testing Technologies and Emerging Markets
US$ 19,120.00
... contributing to the rise in incidence of opportunistic infections, threat of bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immunosuppressive drugs. The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry ...
November 2012
1900 pages
Innovative Molecular Diagnostic Technologies and Emerging Markets
US$ 19,040.00
... entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during this decade. The report explores business and technological trends in the US, five major European countries, (France, Germany, Italy, Spain, UK) and Japan; ...
November 2012
1050 pages
EEG/EMG/Brain Function Monitoring: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for EEG/EMG/Brain Function Monitoring in US$ Million by the following Product Segments: Electroencephalograph Equipment, ... Nihon Kohden Corporation, Nihon Kohden America, Inc., and Noraxon U.S.A., Inc. Market data and analytics are derived from primary and secondary ...
October 2012
347 pages
KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen
US$ 7,495.00
... with the greatest insight into how HCV clinical research will shape the future market. Key Benefits Hepatitis C: the race for the first interferon-free regimen examines the most prominent insights gained from the ... generation protease inhibitors Develop planning strategies based on insight from the field’s foremost KOLs Identify the unmet needs and opportunities for ...
October 2012
246 pages
US Prenatal Testing Market Report: 2012 Edition
US$ 800.00
... posing acute challenges. This report provides a comprehensive overview of the US prenatal testing market covering the market opportunity for the T21 tests. The prenatal testing realm is getting intensely ...
October 2012
42 pages
Analysis of Blood Banking Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
This 68-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...
September 2012
68 pages
Analysis of Blood Banking Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 114 pages
September 2012
114 pages
Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
September 2012
185 pages
Analysis of Molecular Diagnostics Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, ...
September 2012
103 pages
Analysis of Emerging Immunodiagnostic Tests And Strategic Profiles of Leading Suppliers
US$ 3,160.00
... of companies developing or marketing new technologies and products. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new ...
September 2012
240 pages
Analysis of Emerging Hemostasis Tests And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... . The report also includes strategic assessments of current and emerging suppliers of hemostasis diagnostic products, including marketing tactics, technological know-how ... pages and 19 tables Synopsis "This 165-page report presents the clinical significance and market needs for major hemostasis laboratory ...
September 2012
165 pages
Analysis of Emerging Microbiology Tests and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... of companies developing or marketing innovative technologies and products. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new ...
September 2012
760 pages
US Market Changes in the Treatment of Advanced Prostate Cancer
US$ 2,900.00
Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence ...
September 2012
30 pages
US Market Changes in the Treatment of Advanced Melanoma
US$ 2,900.00
... regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.
September 2012
31 pages
Analysis of Emerging Coagulation Tests and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... companies developing or marketing new coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ...
September 2012
165 pages
US Market Changes in the Treatment of Advanced Breast Cancer
US$ 2,900.00
... of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to determine trends across time and changes in practice patterns in the management of advanced breast cancer.
September 2012
34 pages
US Market Changes in the Treatment of Advanced Lung Cancer
US$ 2,900.00
The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended ...
September 2012
39 pages
US Market Changes in the Treatment of Non-Hodgkin's Lymphoma
US$ 2,900.00
... factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 using parallel cases to determine trends across time and changes in practice patterns in the management of non-Hodgkin’s lymphoma.
September 2012
46 pages
Future Horizons in the European Coagulation Testing Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... business opportunities emerging in the coagulation market during the next five years. The report explores business and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides estimates of the test volume, as well as sales and market shares of leading competitors; ...
September 2012
500 pages
Future Horizons in the European Clinical Chemistry and Immunodiagnostics Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM
US$ 14,800.00
... and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major ...
September 2012
900 pages
